216 related articles for article (PubMed ID: 6231602)
1. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Grenier B; Gilly R
Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
[TBL] [Abstract][Full Text] [Related]
2. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
3. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
4. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
Michalsen H; Bergan T
Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
[TBL] [Abstract][Full Text] [Related]
5. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
[TBL] [Abstract][Full Text] [Related]
6. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
Konopka CA
Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
[TBL] [Abstract][Full Text] [Related]
8. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
10. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Lau WK; Young LS; Osher AB; Dooley RR
Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis.
Bosso JA; Black PG
Pediatr Infect Dis J; 1988 Mar; 7(3):171-6. PubMed ID: 3128767
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
Schaad UB; Desgrandchamps D; Kraemer R
Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
[TBL] [Abstract][Full Text] [Related]
13. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Michalsen H; Bergan T
Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
[TBL] [Abstract][Full Text] [Related]
14. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A; Hodson ME; Gaya H; Batten JC
Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
Smith AL; Doershuk C; Goldmann D; Gore E; Hilman B; Marks M; Moss R; Ramsey B; Redding G; Rubio T; Williams-Warren J; Wilmott R; Wilson HD; Yogev R
J Pediatr; 1999 Apr; 134(4):413-21. PubMed ID: 10190914
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.
Schaad UB; Wedgwood-Krucko J; Suter S; Kraemer R
J Pediatr; 1987 Oct; 111(4):599-605. PubMed ID: 3309236
[TBL] [Abstract][Full Text] [Related]
17. [Role of azlocillin in the treatment of Pseudomonas aeruginosa otitis in children].
Damay M; Ployet MJ; Borderon JC
Presse Med; 1984 Mar; 13(13):812-4. PubMed ID: 6231601
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.
Steinkamp G; Tümmler B; Malottke R; von der Hardt H
Arch Dis Child; 1989 Jul; 64(7):1022-8. PubMed ID: 2517000
[TBL] [Abstract][Full Text] [Related]
20. Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.
Gaillard JL; Cahen P; Delacourt C; Silly C; Le Bourgeois M; Coustère C; de Blic J; Lenoir G; Scheinmann P
Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):291-6. PubMed ID: 7649191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
